Figure 2From: CD44 but not CD24 expression is related to poor prognosis in non-cardia adenocarcinoma of the stomach mRNA expression levels of CD24 and CD44. Quantification by reverse transcription-polymerase chain reaction showed that CD24 (A) and CD44 (B) levels were significantly higher in immunohistochemically positive compared with immunohistochemically negative groups, respectively. *, P < 0.001.Back to article page